Researchers at the University of Pennsylvania School of Medicine have found that a commonly prescribed diabetes drug kills tumour cells that lack a key regulatory gene called p53. Results from current
More: continued here
Blogsphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg
RSS feed for comments on this post | TrackBack URI for this post
Best Deal Ads :






